1-10 of 10
Andrew L. Kung
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Translational Strategies for Repotrectinib in Neuroblastoma

Available to Purchase
Tara J. O'Donohue, Glorymar Ibáñez, Diego Ferreira Coutinho, Audrey Mauguen, Armaan Siddiquee, Nestor Rosales, Paul Calder, Andoyo Ndengu, Daoqi You, Matthew Long, Stephen S. Roberts, Andrew L. Kung, Filemon S. Dela Cruz
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2021) 20 (11): 2189–2197.
https://doi.org/10.1158/1535-7163.MCT-21-0126
Published: 01 November 2021
View articletitled, Translational Strategies for Repotrectinib in Neuroblastoma
Open the PDF for Translational Strategies for Repotrectinib in Neuroblastoma in another window
Includes: Supplementary data
Journal Articles

Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma

Available to Purchase
John A. DeSisto, Patrick Flannery, Rakeb Lemma, Amrita Pathak, Shelby Mestnik, Natalie Philips, Natalie J. Bales, Trinayan Kashyap, Erin Moroze, Sujatha Venkataraman, Andrew L. Kung, Bruce D. Carter, Yosef Landesman, Rajeev Vibhakar, Adam L. Green
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (2): 540–551.
https://doi.org/10.1158/1535-7163.MCT-18-1319
Published: 06 February 2020
View articletitled, Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma
Open the PDF for Exportin 1 Inhibition Induces Nerve Growth Factor Receptor Expression to Inhibit the NF-κB Pathway in Preclinical Models of Pediatric High-Grade Glioma in another window
Includes: Supplementary data
Journal Articles

Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma

Free
Lisa Giulino-Roth, Herman J. van Besien, Tanner Dalton, Jennifer E. Totonchy, Anna Rodina, Tony Taldone, Alexander Bolaender, Hediye Erdjument-Bromage, Jouliana Sadek, Amy Chadburn, Matthew J. Barth, Filemon S. Dela Cruz, Allison Rainey, Andrew L. Kung, Gabriela Chiosis, Ethel Cesarman
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (9): 1779–1790.
https://doi.org/10.1158/1535-7163.MCT-16-0848
Published: 04 September 2017
View articletitled, Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma
Open the PDF for Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma in another window
Includes: Supplementary data
Journal Articles

Antiproliferative Effects of CDK4/6 Inhibition in CDK4-Amplified Human Liposarcoma In Vitro and In Vivo

Free
Yi-Xiang Zhang, Ewa Sicinska, Jeffrey T. Czaplinski, Stephen P. Remillard, Samuel Moss, Yuchuan Wang, Christopher Brain, Alice Loo, Eric L. Snyder, George D. Demetri, Sunkyu Kim, Andrew L. Kung, Andrew J. Wagner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (9): 2184–2193.
https://doi.org/10.1158/1535-7163.MCT-14-0387
Published: 02 September 2014
View articletitled, Antiproliferative Effects of CDK4/6 Inhibition in CDK4-Amplified Human Liposarcoma In Vitro and In Vivo
Open the PDF for Antiproliferative Effects of CDK4/6 Inhibition in CDK4-Amplified Human Liposarcoma In Vitro and In Vivo in another window
Includes: Supplementary data
Journal Articles

Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer

Free
Luiz Fernando Zerbini, Manoj K. Bhasin, Jaira F. de Vasconcellos, Juliano D. Paccez, Xuesong Gu, Andrew L. Kung, Towia A. Libermann
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2014) 13 (7): 1929–1941.
https://doi.org/10.1158/1535-7163.MCT-13-0750
Published: 06 July 2014
View articletitled, Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer
Open the PDF for Computational Repositioning and Preclinical Validation of Pentamidine for Renal Cell Cancer in another window
Includes: Supplementary data
Journal Articles

Molecular and Cellular Effects of NEDD8-Activating Enzyme Inhibition in Myeloma

Free
Douglas W. McMillin, Hannah M. Jacobs, Jake E. Delmore, Leutz Buon, Zachary R. Hunter, Val Monrose, Jie Yu, Peter G. Smith, Paul G. Richardson, Kenneth C. Anderson, Steven P. Treon, Andrew L. Kung, Constantine S. Mitsiades
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (4): 942–951.
https://doi.org/10.1158/1535-7163.MCT-11-0563
Published: 08 April 2012
View articletitled, Molecular and Cellular Effects of NEDD8-Activating Enzyme Inhibition in Myeloma
Open the PDF for Molecular and Cellular Effects of NEDD8-Activating Enzyme Inhibition in Myeloma in another window
Includes: Supplementary data
Journal Articles

Abstract A236: Human liposarcoma growth inhibition by novel CDK4/6 inhibitor LEE011.

Free
Yixiang Zhang, Ewa Sicinska, Samuel Moss, Jeffrey T. Czaplinski, Yuchuan Wang, Christopher Brain, George D. Demetri, Sunkyu Kim, Andrew L. Kung, Andrew J. Wagner
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A236.
https://doi.org/10.1158/1535-7163.TARG-11-A236
Published: 12 November 2011
View articletitled, Abstract A236: Human liposarcoma growth inhibition by novel CDK4/6 inhibitor LEE011.
Journal Articles

Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors

Free
Ellen Weisberg, Hwan Geun Choi, Rosemary Barrett, Wenjun Zhou, Jianming Zhang, Arghya Ray, Erik A. Nelson, Jingrui Jiang, Daisy Moreno, Richard Stone, Ilene Galinsky, Edward Fox, Sophia Adamia, Andrew L. Kung, Nathanael S. Gray, James D. Griffin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2010) 9 (9): 2468–2477.
https://doi.org/10.1158/1535-7163.MCT-10-0232
Published: 08 September 2010
View articletitled, Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors
Open the PDF for Discovery and Characterization of Novel Mutant FLT3 Kinase Inhibitors in another window
Includes: Supplementary data
Journal Articles

Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells

Free
Ellen Weisberg, Renee D. Wright, Douglas W. McMillin, Constantine Mitsiades, Arghya Ray, Rosemary Barrett, Sophia Adamia, Richard Stone, Ilene Galinsky, Andrew L. Kung, James D. Griffin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2008) 7 (5): 1121–1129.
https://doi.org/10.1158/1535-7163.MCT-07-2331
Published: 15 May 2008
View articletitled, Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells
Open the PDF for Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells in another window
Includes: Supplementary data
Journal Articles

Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells

Free
Ellen Weisberg, Andrew L. Kung, Renee D. Wright, Daisy Moreno, Laurie Catley, Arghya Ray, Leigh Zawel, Mary Tran, Jan Cools, Gary Gilliland, Constantine Mitsiades, Douglas W. McMillin, Jingrui Jiang, Elizabeth Hall-Meyers, James D. Griffin
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (7): 1951–1961.
https://doi.org/10.1158/1535-7163.MCT-06-0810
Published: 09 July 2007
View articletitled, Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells
Open the PDF for Potentiation of antileukemic therapies by Smac mimetic, LBW242: effects on mutant FLT3-expressing cells in another window
Includes: Supplementary data